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Ischemia/reperfusion (IR) injury can induce skeletal muscle ﬁbre death and subsequent regeneration. By 14 days, absolute and
speciﬁc maximal forces and fatigue resistance in ischemic/reperfused soleus muscles were still reduced (−89%, −81%, and −75%,
resp.) as compared to control muscles (P<. 05). The decrease of these parameters in ischemic/reperfused muscle was much
greater than that of myotoxic injured muscles (−12%, −11%, and −19%; P<. 05). In addition, at 14 days ischemic/reperfused
musclestructurewasstillabnormal,showingsmallmuscleﬁbresexpressingneonatalmyosinheavychainandlargenecroticmuscle
ﬁbres that were not observed in myotoxin treated muscles. By 56 days, in contrast to myotoxin treated muscles, speciﬁc maximal
force and muscle weight of the ischemic/reperfused muscles did not fully recover (P<. 05). This diﬀerential recovery between
ischemic/reperfused and myotoxin treated muscles was not related to the diﬀerences in the initial cell death, loss of satellite cells
after injury, expression of growth factors (IGF1, IGF2..), or capillary density in regenerating muscles. In conclusion, our results
demonstrate that IR injury in mice induces long term detrimental eﬀects in skeletal muscles and that the recovery following IR
injury was delayed for yet unknown reasons as compared to myotoxic injury.
1.Introduction
Restoration of blood ﬂow after a period of ischemia causes
ischaemia-reperfusion injury (IR). IR injury is a serious clin-
icalproblemthatoccursinmanydiseases(myocardialinfarc-
tion, trauma, tourniquet application as well as in certain
neuromuscular diseases). Animal models of IR have been
widely used to study the pathophysiology and consequences
ofIRinjury,aswellasincellularandgenetherapies.IRinjury
causes acute vascular leakage, nerve and skeletal muscle
damage with consecutive deﬁcit in neuromuscular function
[1–3].Mastcells,neutrophils,inﬂammatorycytokines,nitric
oxide, and reactive oxygen species most likely play a role in
the ﬁnal damage which is observed in the skeletal muscle
[1, 3, 4].
IR injury lasting for more than 2 hours causes extensive
skeletal muscle ﬁbre death. Since skeletal muscle is capable
of regenerating following injury, subsequent formation of
regenerating muscle ﬁbres will occur in the following days.
However, it was recently reported that at day 14 following
4 hours of IR injury complete recovery of muscle function
had not been achieved [5]. Previous studies have also
demonstrated that full recovery of muscle after myotoxin
injurycantakeseveralweeks[6].Therefore,itisimportantto
study long-term muscle recovery following IR injury leading
to cell death. A few studies have been carried out on long-
term muscle recovery following IR injury but most probably
they did not induce massive cell death in the models that
were used [7, 8]. In contrast to Carvalho et al. [7], Fish et al.
[8] found that full muscle recovery was not reached 42 days2 Journal of Biomedicine and Biotechnology
after2hoursofischemiasincemaximalforceproductionwas
still reduced in ischemic-reperfused muscles as compared to
control muscles in rats.
We report here the results of experiments in mice,
aimed at assessing the long-term outcome of IR injury
in mouse hind limb muscles. We wanted to determine
whether there is a full recovery of muscle function following
an IR injury leading to extensive cell death. In order to
have a better understanding of the potential eﬀects of
IR injury, ischemic/reperfused muscles were compared to
myotoxin-treated muscles. The administration of myotoxic
agents results in extensive muscle ﬁbre necrosis [6, 9, 10],
without disrupting nerve branches and blood vessels that are
elements known to play a major role in muscle repair [11,
12].Ourﬁndingsindicatethatmusclerepairwaslesseﬃcient
following IR injury as compared to that observed after
myotoxin injury. These results could provide helpful knowl-
edgeinrelationtobothvascularandneuromusculardiseases.
2.MaterialsandMethods
2.1. Animals. A l lp r o c e d u r e sw e r ep e r f o r m e di na c c o r d a n c e
with national and European legislations, using young adult
rodents (3–6 month old). IR or myotoxic injury was
performed on the right legs of male C57BL6 or Myf5-nlacZ
(a gift from F. Relaix, INSERM U787, Paris) mice and the
tibialis anterior muscles were studied. Animals were anaes-
thetised with pentobarbital (60mg/kg), with supplemental
anesthesia as needed. A few hours after IR and myotoxic
injury, the animals recuperated a normal mobility.
2.2. Ischemia/Reperfusion Injury. In order to generate uni-
lateral hindlimb ischemia the mice were kept on a heating
pad to maintain the body temperature at 37◦C and the right
hindlimbs were made ischemic by placing rubber bands high
on the thigh. After 3 hours of ischaemia, the bands were
removed. Contralateral (left) legs were left intact and were
used as control (nonischemic/reperfused) muscles.
2.3. Myotoxic Injury. E x t e n s i v em u s c l en e c r o s i sw a sc r e a t e d
by injecting cardiotoxin, a myotoxic agent, into the muscles
[6, 9, 10]. Cardiotoxin (C-3987, Sigma-Aldrich, 10μM) was
injected into right tibialis anterior in 70μlo fn o r m a ls a l i n e .
A needle connected to a microsyringe was inserted near to
the distal tendon, pushed up to the proximal tendon, and the
cardiotoxin solution was injected into the muscle, the needle
being pulled up in order to deliver the solution all along the
muscle.Contralateral(left)legswereleftintactandwereused
to provide control (myotoxin untreated) muscles.
2.4. Contractile Measurements. Muscle function was eval-
uated by the measurement of in situ muscle contraction
in response to nerve stimulation, as previously described
[13]. At 14, 28, and 56 days after injury, animals were
anesthetized (pentobarbital 60mg/kg). During experiments,
supplemental doses were given as required to maintain
deep anesthesia. The knee and foot were ﬁxed with clamps
and pins. The distal tendon of the tibialis anterior (TA)
muscles were attached to an isometric transducer (Harvard
Bioscience) using a silk ligature. All data provided by the
isometrictransducerwererecordedandanalyzedonamicro-
computer, using the PowerLab system (4SP, ADInstruments)
and software (Chart 4, ADInstruments). The sciatic nerves
were proximally crushed and distally stimulated by a bipolar
silver electrode using supramaximal square wave pulses of
0.1ms duration. All isometric measurements were made at
an initial muscle length of L0 (length at which maximal
tensionwasobtainedduringthetwitch).Responsestotetanic
stimulation (pulse frequency 50–143Hz, 500ms duration)
were successively recorded. At least 1 minute was allowed
between contractions. Absolute maximal tetanic forces (P0)
were determined. Muscle masses (m) were measured to cal-
culate speciﬁc tensions (P0/m). Fatigue resistance (FR) was
then determined after a 5 minutes rest period. The muscle
wascontinuouslystimulatedat50Hzduring2minutes(sub-
maximal continuous tetanus). The duration corresponding
to a force decreased by 20% was noted FR. Body temperature
was maintained at 37◦C using radiant heat. After contractile
measurements, the animals were killed with an overdose of
pentobarbital. Muscles were then weighed, frozen in liquid
nitrogen, respectively, precooled in isopentane and stored at
−80◦C until histological and other analyses.
2.5. Histology. Transverse serial frozen sections of TA mus-
cles (8μm) were obtained using a cryostat. Some of the
sections were stained with hematoxylin and eosin solution,
or Sirius red stain and others were used for immunohisto-
chemistry. For immunohistochemistry, frozen sections were
ﬁxed 10 minutes in 2% paraformaldehyde and incubated
overnight in a blocking solution (BSA 1%, sheep serum 1%,
triton X-100 0.3%). Sections were then incubated with either
a mouse antibody directed against neonatal MHC, or a rat
antibody directed against CD31 (Pharmingen, 553370) in
order to measure muscle capillary bed density. The antibody
against neonatal MHC was prepared as previously described
[14]. The neonatal antibody had previously been shown
to react with mouse neonatal heavy chain but not with
mouse adult fast MHC [15]. Sections were then washed
four times in phosphate-buﬀered saline (PBS) and incubated
with a Cy3 AﬃniPure Goat Anti-Rabbit IgG (H+L) (111-
165-144, Jackson ImmunoResearch), or Alexa Fluor 488
goat anti-rat IgG (H+L) (A11006, Invitrogen). After four
washes in PBS slides were mounted in a mounting solution
(mowiol/dabco/hoechst). Images were acquired using a
digital camera mounted on a bright-ﬁeld or a ﬂuorescence
microscope.
2.6. Satellite Cell Number. The number of satellite cells was
determined using the Myf5-nlacZ heterozygous mice [16],
which have a reporter gene encoding nuclear-localizing b-
galactosidase (nlacZ), targeted to the Myf5 locus. nlacZ
reporter gene-β-Gal activity was detected histochemically as
previously described [17, 18]. The majority of quiescent and
activated satellite cells expressed Myf5 [17, 18].
2.7. Cytokine Antibody Array. RayBio Mouse Cytokine Anti-
body C Series 1000 kit (RayBiotech) was used for estimating
the diﬀerential amount of cytokines in pooled proteinJournal of Biomedicine and Biotechnology 3
extracts, accordingly to the manufacturer’s instructions.
Only a selection of cytokines is shown, on the basis of
their role in muscle repair. The complete list of cytokines
and their full names are available on the manufacturer’s
web site. Muscle proteins were extracted with Array Lysis
Buﬀer (kit component) and incubated at ﬁnal concentration
of 1μg/μl. Each membrane was blocked and incubated
with protein extracts. Membranes were washed and then
incubated with a biotin-conjugated antibody for 2 hours.
Finally, the membranes were washed, incubated with HRP-
conjugated streptavidin at room temperature for 1 hour and
with detection buﬀer for 1 minute, and exposed to Fuji
Film LAS-4000. The intensities of signals were quantiﬁed
by densitometric analysis with Multi Gauge V 3.0 software
and the positive control (biotin-conjugated IgG) was used to
normalize the results from each membrane. We performed
proteomic analyses using 3 diﬀerent pooled samples from
4-5 animals/group (ischemic-reperfused muscles, myotoxin-
treated and untreated muscles).
2.8. Statistical Analysis. Data were analysed using Statistica
5.5 software (StatSoft, Paris, France). Ischemic/reperfused
muscles or myotoxin-treated muscles were statistically com-
paredtocontrolmusclesusingvarianceanalysis.Ifnecessary,
subsequent contrast analysis was also performed. Values
of IR muscles and myotoxin-treated muscles were also
expressed as a percentage of control (normal) muscles, that
is, contralateral muscles. Values are means ± SEM.
3. Results
3.1. Eﬀect of IR Injury. At 14 days after IR in contrast to
control muscles (Figure 1(a)), ischemic/reperfused muscles
exhibited centronucleated muscle ﬁbres of small diameter
(regenerating muscle ﬁbres, Figure 1(c)) and “ghosts” that
are most likely dead muscle ﬁbres that have not yet
disappeared (Figure 1(d)). These observations indicate that
IR injury resulted in extensive muscle ﬁbre death, with no
apparent survival of muscle ﬁbres and induced insuﬃcient
muscle regeneration by day 14. In order to have a wider
insight on the potential eﬀects of IR, ischemic/reperfused
muscles were also compared to myotoxin-treated muscles.
These muscles exhibited similar extensive muscle damage.
However, regeneration was more advanced and more homo-
geneous since centronucleated muscle ﬁbres ﬁlled >90%
of the muscle cross-section of myotoxin-treated muscles
(Figure 1(b)). Fibrosis, based on Sirius Red stainings, was
also observed in ischemic/reperfused muscles (Figure 1(h)).
Muscle function also shows drastic changes after IR
injury. By 14 days, absolute maximal force (P0, Figure 2),
speciﬁc maximal force (P0/m, Figure 3), fatigue resis-
tance (FR, Figure 4) and muscle weight (Figure 5)w e r e
still markedly reduced in ischemic/reperfused muscles as
compared to control muscles (P<. 05). The fact that
absolute maximal force was reduced by 89% at day 14
conﬁrmed that none of the muscle ﬁbres had survived to
IR injury. In contrast, we found no signiﬁcant diﬀerence
between myotoxin-treated muscles and control muscles at
day 14 (Figures 2–5). Accordingly, the levels of recovery (%
o fc o n t r o lm u s c l e s )o fa b s o l u t em a x i m a lf o r c e( Figure 2)
and speciﬁc maximal force (Figure 3), fatigue resistance
(Figure 4), and weight (Figure 5) in ischemic/reperfused
muscles were reduced when compared to myotoxin-treated
muscles,byday14.Byday28,thelevelofrecoveryofabsolute
maximal force and weight in ischemic/reperfused muscles
was still lower as compared to myotoxin-treated muscles
(Figures 2 and 5, P<. 05). By 56 days, ischemic/reperfused
muscles fully recovered absolute maximal force (Figure 2)
and fatigue resistance (Figure 4). However, speciﬁc maximal
force (Figure 3) was still reduced in ischemic/reperfused
muscles as compared to control muscles, by day 56
(P<. 05). This last result was explained by the fact
that ischemic/reperfused muscles were heavier by day 56
(Figure 5, P<. 05) whereas absolute maximal force was
normal (Figure 2).
3.2. Further Analysis of Injured Muscles. To determine
whether the diﬀerence in muscle recovery between the
ischemic/reperfused and myotoxin-treated muscles was
related to delayed muscle regeneration, we analysed the
expressionofneonatalmyosinheavychain(MHC),thatisan
MHC isoform expressed at the earlier stage of muscle repair.
We found that neonatal MHC was still strongly expressed
in ischemic/reperfused muscles (Figure 1(e))a td a y1 4b u t
not in myotoxin-treated muscles (Figure 1(f)), conﬁrming
delayed muscle regeneration.
It has been previously documented that a reduced blood
supply impairs muscle recovery following injury [19]. To
test the hypothesis that a reduction in muscle blood supply
could explain the diﬀerence between ischemic/reperfused
and myotoxin-treated muscles, we also analysed muscle
capillarity. At day 14, we observed that there was no
diﬀerence in capillary density between ischemic/reperfused
and myotoxin-treated muscles (Figure 6).
We next analysed some of the earlier events in muscle
regeneration to try to explain the delayed muscle regener-
ation observed in the IR group. Since cytokines are known
to be involved both in proliferation and diﬀerentiation
we examined the expression of selected cytokines using
a cytokine antibody array that was performed on muscle
extracts obtained at day 7. We did not ﬁnd any marked
diﬀerence between these two types of muscle injury con-
cerning the level of growth factors (IGF-1, IGF-2, FGF-2,...)
classically involved in muscle repair [20]( Table 1). However,
some results did show diﬀerences in the 2 types of injured
muscles. For example, proteins contributing to angiogen-
esis (VEGFR1), extracellular matrix remodeling (MMP-2
and MMP-3) were not upregulated in ischemic/reperfused
muscles as compared to myotoxin injured muscles, whereas
some factors regulating the activation and migration of
leukocytes in injured tissues (MIP-1, MIP-2 and MIP-3) and
inﬂammation (sTNF R1 and sTNF R2) were increased in
ischemic/reperfused muscles (Table 1).
Muscle ﬁbers are regenerated by the activation and
proliferation of satellite cells that fuse together to form
myotubes. To determine whether the deﬁcient regeneration
observed in ischemic/reperfused muscles was the result of
a reduced satellite cell pool, the number of cells expressing4 Journal of Biomedicine and Biotechnology
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Figure 1: Cross-section of muscles after IR injury and myotoxic injury. Cross-sections 14 days after injury was stained with hematoxylin and
eosin solution ((a), (b), (c), (d)) or revealed for neonatal MHC reactivity ((e), (f)). Cross-section 2 months after IR injury were stained with
Sirius red stain ((g), (h)). ((a), (g)) control muscles (corresponding to myotoxin-treated muscles); ((c), (d), (e), (h)) Ischaemic/reperfused
muscles (IR+); ((b), (f)) myotoxin-treated muscles (MI+).
Myf5 was measured after 3 hours of reperfusion. We found
that ischemic/reperfused muscles contained a lower number
of Myf5 cells as compared to control muscles (P<. 05,
Figure 7). However the loss of Myf5 cells was similar in
ischemic/reperfused and myotoxin-treated muscles muscles
(Figure 7).
4. Discussion
The aim of this study was to examine the long-term
consequence of IR injury on murine hindlimb skeletal
muscles. Very little information exists on the rate and on the
ultimate extent of muscle recovery following IR injury in this
animalmodel.OurﬁndingsindicatethatIRinjuryhasalong
lasting and detrimental eﬀect on muscle recovery.
Reduced ATP production [7] and mitochondrial dys-
function [2] are the cause of the extensive cellular death after
IR injury. Consequently there is a very marked reduction
in muscle function observed just after IR [5, 7, 21]. Our
results indicate that maximal force and fatigue resistance in
ischemic-reperfused muscles were still markedly reduced 14
days after IR injury, in agreement with previous observations
[5, 21]. At this time point, the deﬁcit in absolute maximal
force production (−89%) can be explained by the decrease
in muscle mass and in speciﬁc maximal force. This was
related to the poor muscle ﬁbre regeneration, since there
wereregionsofthemusclecrosssectionwithnoregeneratingJournal of Biomedicine and Biotechnology 5
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Figure 2: Maximal tetanic force (P0) of muscles after ischemia-
reperfusion injury and myotoxic injury. Values are means ± SEM.
Number of data per group is 4–6. IR+: ischaemic/reperfused
muscles, IR−: control muscles of ischaemic/reperfused muscles,
M+: myotoxin-treated muscles, M−: control muscles of myotoxin-
treated muscles. (a) signiﬁcantly diﬀerent from control (P<. 05),
(b) signiﬁcantly diﬀerent from 28 days (P<. 05), (c) signiﬁcantly
diﬀerent from 56 days (P<. 05), (d) signiﬁcantly diﬀerent from
M+.
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Figure 3: Speciﬁc maximal tetanic force (P0/m) of muscles
after ischemia-reperfusion injury and myotoxin injury. Val-
ues are means ± SEM. Number of data per group is 4–
6. IR+: ischaemic/reperfused muscles, IR−: control muscles of
ischaemic/reperfusedmuscles,M+:myotoxin-treatedmuscles,M−:
control muscles of myotoxin-treated muscles. (a) signiﬁcantly
diﬀerent from control (P<. 05), (b) signiﬁcantly diﬀerent from 28
days (P<. 05), (c) signiﬁcantly diﬀerent from 56 days (P<. 05), (d)
signiﬁcantly diﬀerent from M+.6 Journal of Biomedicine and Biotechnology
0
5
10
15
20
F
R
(
s
)
a
IR+ IR− IR+ IR− IR+ IR−
(a)
0
5
10
15
20
F
R
(
s
)
M+ M− M+ M− M+ M−
(b)
0
50
100
150
F
R
(
c
o
n
t
r
o
l
%
)
IR+ M+ IR+ M+ IR+ M+
a
b
c
d
14 days
28 days
56 days
(c)
Figure 4: Fatigue resistance of muscles after ischemia-reperfusion
injury and myotoxin injury. Values are means ± SEM. Number
of data per group is 4–6. IR+: ischaemic/reperfused muscles, IR−:
control muscles of ischaemic/reperfused muscles, M+: myotoxin-
treated muscles, M−: control muscles of myotoxin-treated muscles.
(a) signiﬁcantly diﬀerent from control (P<. 05), (b) signiﬁcantly
diﬀerent from 28 days (P<. 05), (c) signiﬁcantly diﬀerent from 56
days (P<. 05), (d) signiﬁcantly diﬀerent from M+.
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Figure 5: Muscle weights after ischemia-reperfusion injury and
myotoxic injury. Values are means ± SEM. Number of data per
group is 4–6. IR+: ischaemic/reperfused muscles, IR−:c o n t r o l
muscles of ischaemic/reperfused muscles, M+: myotoxin-treated
muscles, M−: control muscles of myotoxin-treated muscles-do
not you-mean contralateral muscle of myotoxin-treated mice?. (a)
signiﬁcantly diﬀerent from control (P<. 05), (b) signiﬁcantly
diﬀerent from 28 days (P<. 05), (c) signiﬁcantly diﬀerent from 56
days (P<. 05), (d) signiﬁcantly diﬀerent from M+.Journal of Biomedicine and Biotechnology 7
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Figure 6: Capillary density 14 days after ischemia-reperfusion injury and myotoxic injury. Values are means ± SEM. Number of data per
group is 3. IR+: ischaemic/reperfused muscles, IR−: control muscles of ischaemic/reperfused muscles, M+: myotoxin-treated muscles, M−:
control muscles of myotoxin-treated muscles.
muscle ﬁbres, resulting in a reduced number of cross-bridges
in parallel. Modiﬁed neuromuscular transmission cannot be
excluded, although a recent study reports that nerve and
muscle stimulation resulted in similar force production by
day 14 [5].
Full recovery of absolute maximal force and fatigue
resistance occurred by days 28 and 56. However, even at
56 days speciﬁc maximal force production was still lower
in ischemic-reperfused muscles (−17.5%) as compared to
control muscles. One reason leading to the long-term
deﬁcit in speciﬁc maximal force is that ischaemia-reperfused
muscles exhibit a lower density of cross-bridges due to
increased ﬁbrosis (as shown at days 56). In contrast,
myotoxin-treated muscles fully recovered. Therefore our8 Journal of Biomedicine and Biotechnology
Table 1: Cytokine expressed in the ischemic-reperfused and
myotoxin-treated muscles at day 7.
IR+ (% uninjured) MI+ (% uninjured)
Myogenesis
IGF-I 71 63
IGF-II 43 64
IGFBP-2 65 65
IGFBP-3 107 122
IGFBP-5 109 126
IGFBP-6 109 110
bFGF 106 97
HGF R 0 19
Angiogenesis
VEGF 132 113
VEGF R1 103 138
VEGF R2 0 0
VEGF R3 0 0
VEGF-D 0 0
ECM remodelling
MMP-2 65 153
MMP-3 87 52
TIMP-1 93 85
TIMP-2 96 73
Pro-MMP-9 44 48
Chemokines
Fractalkine 111 90
GCSF 95 91
GM-CSF 91 97
KC (IL8) 129 113
MCP1 75 85
MCP-5 72 79
MIP-1 136 104
MIP-1 196 135
MIP-2 146 119
MIP-3 153 113
MIP-3 132 118
RANTES 119 141
Inﬂammation
IL-1 b 117 94
IL-6 89 69
TNF 107 92
sTNF RI 146 94
sTNF RII 135 102
results suggest that complete recovery of mouse hindlimb
skeletal muscles might never be reached after IR injury,
with IR injury reducing the ﬁnal extent of muscle repair.
Thus the long-term consequence of IR injury is that muscle
might be heavier (+18.7%) to produce a normal level of
maximal force, indicating that the functional “quality” of
ischemia-reperfused muscle is lower. Interestingly, a deﬁcit
in speciﬁc maximal force is also observed in the murine
model of Duchenne muscular dystrophy, the mdx mice
(−20–25% [22]). Thus our ﬁndings substantiate the concept
that myopathy is an aspect of peripheral arterial occlusive
disease [2, 3].
Another important ﬁnding of the present study is that
the level of recovery of maximal force, fatigue resistance
and muscle weight was delayed in ischaemia-reperfused
muscles as compared to myotoxin-treated muscles at day 14.
The diﬀerences between ischaemia-reperfused and myotoxic
injury were not a result of greater initial injury in the
ischaemia-reperfused muscles since all muscle ﬁbers were
destroyed by both types of injury. Interestingly, in contrast to
myotoxic injury, at 14 days postinjury developmental MHC
was not downregulated in ischaemia-reperfused mucles.
Therefore our results indicate that muscle regeneration is
not only unable to restore normal characteristics but is also
delayed following IR injury.
Diﬀerential muscle repair between ischemic-reperfused
and myotoxin-treated muscles could be explained by diﬀer-
ent reasons. Satellite cells, local environment, blood vessels
and nerve branches are all elements known to play a
major role in muscle regeneration. An explanation of our
ﬁndings could be that part of the satellite cell reservoir,
that is, the main source of regenerating muscle ﬁbers
was lethally aﬀected by ischemia-reperfusion, resulting in
fewer myoblasts, and consequently smaller or less numerous
regenerating muscle ﬁbres. In favour of this explanation
are data suggesting that muscle recovery increases with the
number of satellite cells that escape killing after cryodamage
[23]. However we found that the number of Myf5lacZ cells
(satellitecells)wassimilarlyreducedbyischemia-reperfusion
injuryandmyotoxicinjury.Thefactthatmyotoxicinjurycan
result in satellite cell death was surprising but in agreement
with a recent study [24]. Another possibility could be that
satellite cell activation proliferation or cell fusion are inhib-
itedbythefactthatIRinducedanunfavourableenvironment
to muscle repair, such as diabetes [25]. The inﬂammatory
response must be resolved to allow muscle repair [26]. So
it is plausible that the reduced muscle repair was the result
of a prolonged and combined eﬀect of oxidative stress and
inﬂammation induced by IR injury [1, 3]. Our cytokine
antibody array supports this hypothesis. In contrast to
myotoxin-treated muscles, some chemokines and markers
of inﬂammation are still increased in ischemic/reperfused
muscles at day 7. However, the reduced muscle repair
that we observed was not caused by a decrease in growth
factors that are key players of muscle regeneration (IGF-
1, IGF-2, FGF-2,...), at least at day 7. Blood supply is also
considered to play an important role in muscle repair [11,
12]. This was recently conﬁrmed by a study reporting that
arterial peripheral insuﬃciency decreased muscle recovery
after injury [19]. We therefore hypothesised that the reduced
blood supply due to microvascular leakage observed after
IR [1] explains the reduced muscle recovery after IR injury.
Our ﬁndings showed that by 14 days there was no reduction
in capillarity density. However, our results did not rule
out the possibility of a reduced blood supply at earlier
stage of muscle regeneration. We noted at day 7 a reduced
level of VEGFR1. Finally, it is plausible that terminal nerve
damage could be induced by IR injury [27], resulting inJournal of Biomedicine and Biotechnology 9
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Figure 7: Number of Myf5 cells 3 hours after ischemia-reperfusion
injury and myotoxin injury. Values are means ± SEM. Number
of data per group is 4–6. IR+: ischaemic/reperfused muscles, IR−:
control muscles of ischaemic/reperfused muscles, M+: myotoxin-
treated muscles, M−: control muscles of myotoxin-treated muscles.
(a) signiﬁcantly diﬀerent from control (P<. 05).
a lower level of neuromuscular activity during the early
stage of muscle recovery. It has been reported that although
nervesretractfromtheneuromuscularjunctionimmediately
after myotoxin injury there is a very rapid restoration of a
functional innervation within 3–5 days [11]. Neural activity
and mechanical loading are essential for correct muscle
regeneration after myotoxin injury [28, 29].
5. Conclusion
In this study we have documented the muscle regeneration
that occurs following a period of 3 hours of ischemia in
mice. We show that IR injury results in a long-term deﬁcit
in muscle function. This was the result of a muscle repair
process that was not only delayed but was unable to restore
the normal functional characteristics to the regenerated
muscle. The lower rate and extent of muscle regeneration
after IR injury was not related to a speciﬁc loss of satellite
cells, nor to a decreased capillary bed density or expression
of major growth factors controlling myogenesis. It could
however be related to the prolonged inﬂammation and
oxidative stress that does occur after IR. These results
conﬁrm the necessity to develop ways to prevent muscle
damageinducedbyIRinjury.Theyshouldalsoencouragethe
research of successful therapies that accelerate muscle repair
in the context of vascular deﬁciency or trauma.
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